Evaluation of Nanoparticle Uptake iii Co-culture Cancer Modeis

Co-culture models are currently bridging the gap between classical cultures and in vivo animal models. Exploring this novel approach unlocks the possibility to mimic the tumor microenvironment in vitro, through the establishment of cancer-stroma synergistic interactions. Notably, these organotypic models offer a perfect platform for the development and pre-clinical evaluation of candidate nanocarriers loaded with anti-tumoral drugs in a high throughput screening mode, with lower costs and absence of ethical issues. However, this evaluation was until now limited to co-culture systems established with precise cell ratios, not addressing the natural cell heterogeneity commonly found in different tumors. Therefore, herein the multifunctional nanocarriers efficiency was characterized in various fibroblast-MCF-7 co-culture systems containing different cell ratios, in order to unravel key design parameters that influence nanocarrier performance and the therapeutic outcome. The successful establishment of the co-culture models was confirmed by the tissue-like distribution of the different cells in culture. Nanoparticles incubation in the various co-culture systems reveals that these nanocarriers possess targeting specificity for cancer cells, indicating their suitability for being used in this illness therapy. Additionally, by using different co-culture ratios, different nanoparticle uptake profiles were obtained. These findings are of crucial importance for the future design and optimization of new drug delivery systems, since their real targeting capacity must be addressed in heterogenous cell populations, such as those found in tumors.PEst-OE/EGEJUI4D5G/201

Vortex behavior near a spin vacancy in 2D XY-magnets

The dynamical behavior of anisotropic two dimensional Heisenberg models is still a matter of controversy. The existence of a central peak at all temperatures and a rich structure of magnon peaks are not yet understood. It seems that the central peaks are related, in some way, to structures like vortices. In order to contribute to the discussion of the dynamical behavior of the model we use Monte Carlo and spin dynamics simulations as well analytical calculations to study the behavior of vortices in the presence of nonmagnetic impurities. Our simulations show that vortices are attracted and trapped by the impurities. Using this result we show that if we suppose that vortices are not very much disturbed by the presence of the impurities, then they work as an attractive potential to the vortices explaining the observed behavior in our simulations.Comment: 4 pages, 6 figure

Monte Carlo study of the critical temperature for the planar rotator model with nonmagnetic impurities

We performed Monte Carlo simulations to calculate the Berezinskii-Kosterlitz-Thouless (BKT) temperature $T_{BKT}$ for the two-dimensional planar rotator model in the presence of nonmagnetic impurity concentration $(\rho)$. As expected, our calculation shows that the BKT temperature decreases as the spin vacancies increase. There is a critical dilution $\rho_c \approx 0.3$ at which $T_{BKT} =0$. The effective interaction between a vortex-antivortex pair and a static nonmagnetic impurity is studied analytically. A simple phenomenological argument based on the pair-impurity interaction is proposed to justify the simulations.Comment: 5 pages, 5 figures, Revetex fil

Under-expression Of Chemosensory Genes In Domiciliary Bugs Of The Chagas Disease Vector Triatoma Brasiliensis

In Latin America, the bloodsucking bugs Triatominae are vectors of Trypanosoma cruzi, the parasite that causes Chagas disease. Chemical elimination programs have been launched to control Chagas disease vectors. However, the disease persists because native vectors from sylvatic habitats are able to (re)colonize houses—a process called domiciliation. Triatoma brasiliensis is one example. Because the chemosensory system allows insects to interact with their environment and plays a key role in insect adaption, we conducted a descriptive and comparative study of the chemosensory transcriptome of T. brasiliensis samples from different ecotopes. Methodology/Principal Finding: In a reference transcriptome built using de novo assembly, we found transcripts encoding 27 odorant-binding proteins (OBPs), 17 chemosensory proteins (CSPs), 3 odorant receptors (ORs), 5 transient receptor potential channel (TRPs), 1 sensory neuron membrane protein (SNMPs), 25 takeout proteins, 72 cytochrome P450s, 5 gluthatione S-transferases, and 49 cuticular proteins. Using protein phylogenies, we showed that most of the OBPs and CSPs for T. brasiliensis had well supported orthologs in the kissing bug Rhodnius prolixus. We also showed a higher number of these genes within the bloodsucking bugs and more generally within all Hemipterans compared to the other species in the super-order Paraneoptera. Using both DESeq2 and EdgeR software, we performed differential expression analyses between samples of T. brasiliensis, taking into account their environment (sylvatic, peridomiciliary and domiciliary) and sex. We also searched clusters of co-expressed contigs using HTSCluster. Among differentially expressed (DE) contigs, most were under-expressed in the chemosensory organs of the domiciliary bugs compared to the other samples and in females compared to males. We clearly identified DE genes that play a role in the chemosensory system. Conclusion/Significance: Chemosensory genes could be good candidates for genes that contribute to adaptation or plastic rearrangement to an anthropogenic system. The domiciliary environment probably includes less diversity of xenobiotics and probably has more stable abiotic parameters than do sylvatic and peridomiciliary environments. This could explain why both detoxification and cuticle protein genes are less expressed in domiciliary bugs. Understanding the molecular basis for how vectors adapt to human dwellings may reveal new tools to control disease vectors; for example, by disrupting chemical communication. © 2016 Marchant et al.101

Polypharmacy and specific comorbidities in university primary care settings.

Polypharmacy is associated with adverse events and multimorbidity, but data are limited on its association with specific comorbidities in primary care settings. We measured the prevalence of polypharmacy and inappropriate prescribing, and assessed the association of polypharmacy with specific comorbidities. We did a cross-sectional analysis of 1002 patients aged 50-80years followed in Swiss university primary care settings. We defined polypharmacy as ≥5 long-term prescribed drugs and multimorbidity as ≥2 comorbidities. We used logistic mixed-effects regression to assess the association of polypharmacy with the number of comorbidities, multimorbidity, specific sets of comorbidities, potentially inappropriate prescribing (PIP) and potential prescribing omission (PPO). We used multilevel mixed-effects Poisson regression to assess the association of the number of drugs with the same parameters. Patients (mean age 63.5years, 67.5% ≥2 comorbidities, 37.0% ≥5 drugs) had a mean of 3.9 (range 0-17) drugs. Age, BMI, multimorbidity, hypertension, diabetes mellitus, chronic kidney disease, and cardiovascular diseases were independently associated with polypharmacy. The association was particularly strong for hypertension (OR 8.49, 95%CI 5.25-13.73), multimorbidity (OR 6.14, 95%CI 4.16-9.08), and oldest age (75-80years: OR 4.73, 95%CI 2.46-9.10 vs.50-54years). The prevalence of PPO was 32.2% and PIP was more frequent among participants with polypharmacy (9.3% vs. 3.2%, p<0.006). Polypharmacy is common in university primary care settings, is strongly associated with hypertension, diabetes mellitus, chronic kidney disease and cardiovascular diseases, and increases potentially inappropriate prescribing. Multimorbid patients should be included in further trials for developing adapted guidelines and avoiding inappropriate prescribing

IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in jak2v617f-positive myeloproliferative neoplasms

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)The recurrent V617F mutation in JAK2 (JAK2(V617F)) has emerged as the primary contributor to the pathogenesis of myeloproliferative neoplasms (MPN). However, the lack of complete response in most patients treated with the JAK1/2 inhibitor, ruxolitinib, indicates the need for identifying pathways that cooperate with JAK2. Activated JAK2 was found to be associated with the insulin receptor substrate 2 (IRS2) in non-hematological cells. We identified JAK2/IRS2 binding in JAK2(V617F) HEL cells, but not in the JAK2(WT) U937 cell line. In HEL cells, IRS2 silencing decreased STAT5 phosphorylation, reduced cell viability and increased apoptosis; these effects were enhanced when IRS2 silencing was combined with ruxolitinib. In U937 cells, IRS2 silencing neither reduced cell viability nor induced apoptosis. IRS1/2 pharmacological inhibition in primary MPN samples reduced cell viability in JAK2(V617F)-positive but not JAK2(WT) specimens; combination with ruxolitinib had additive effects. IRS2 expression was significantly higher in CD34(+) cells from essential thrombocythemia patients compared to healthy donors, and in JAK2(V617F) MPN patients when compared to JAK2(WT). Our data indicate that IRS2 is a binding partner of JAK2(V617F) in MPN. IRS2 contributes to increased cell viability and reduced apoptosis in JAK2-mutated cells. Combined pharmacological inhibition of IRS2 and JAK2 may have a potential clinical application in MPN.The recurrent V617F mutation in JAK2 (JAK2V617F) has emerged as the primary contributor to the pathogenesis of myeloproliferative neoplasms (MPN). However, the lack of complete response in most patients treated with the JAK1/2 inhibitor, ruxolitinib, indi7669486959sem informaçãoConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)sem informaçã

Accuracy Of Sonography And Hysteroscopy In The Diagnosis Of Premalignant And Malignant Polyps In Postmenopausal Women [acurácia Da Ultrassonografia E Da Histeroscopia No Diagnóstico De Pólipos Endometriais Pré-malignos E Malignos Na Pós-menopausa]

PURPOSE: To evaluate the accuracy of sonographic endometrial thickness and hysteroscopic characteristics in predicting malignancy in postmenopausal women undergoing surgical resection of endometrial polyps. METHODS: Five hundred twenty-one (521) postmenopausal women undergoing hysteroscopic resection of endometrial polyps between January 1998 and December 2008 were studied. For each value of sonographic endometrial thickness and polyp size on hysteroscopy, the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were calculated in relation to the histologic diagnosis of malignancy. The best values of sensitivity and specificity for the diagnosis of malignancy were determined by the Receiver Operating Characteristic (ROC) curve. RESULTS: Histologic diagnosis identified the presence of premalignancy or malignancy in 4.1% of cases. Sonographic measurement revealed a greater endometrial thickness in cases of malignant polyps when compared to benign and premalignant polyps. On surgical hysteroscopy, malignant endometrial polyps were also larger. An endometrial thickness of 13 mm showed a sensitivity of 69.6%, specificity of 68.5%, PPV of 9.3%, and NPV of 98% in predicting malignancy in endometrial polyps. Polyp measurement by hysteroscopy showed that for polyps 30 mm in size, the sensitivity was 47.8%, specificity was 66.1%, PPV was 6.1%, and NPV was 96.5% for predicting cancer. CONCLUSIONS: Sonographic endometrial thickness showed a higher level of accuracy than hysteroscopic measurement in predicting malignancy in endometrial polyps. Despite this, both techniques showed low accuracy for predicting malignancy in endometrial polyps in postmenopausal women. In suspected cases, histologic evaluation is necessary to exclude malignancy.356243248Anastasiadis, P.G., Koutlaki, N.G., Skaphida, P.G., Galazios, G.C., Tsikouras, P.N., Liberis, V.A., Endometrial polyps: Prevalence, detection, and malignant potential in women with abnormal uterine bleeding (2000) Eur J Gynaecol Oncol., 21 (2), pp. 180-183Clevenger-Hoeft, M., Syrop, C.H., Stovall, D.W., van Voorhis, B.J., Sonohysterography in premenopausal women with and without abnormal bleeding (1999) Obstet Gynecol., 94 (4), pp. 516-520Goldstein, S.R., Zeltser, I., Horan, C.K., Snyder, J.R., Schwartz, L.B., Ultrasonography-based triage for perimenopausal patients with abnormal uterine bleeding (1997) Am J Obstet Gynecol., 177 (1), pp. 102-108Nagele, F., O'Connor, H., Davies, A., Badawy, A., Mohamed, H., Magos, A., 2500 outpatient diagnostic hysteroscopies (1996) Obstet Gynecol., 88 (1), pp. 87-92van Bogaert, L.J., Clinicopathologic findings in endometrial polyps (1988) Obstet Gynecol., 71 (5), pp. 771-773Dreisler, E., Stampe Sorensen, S., Ibsen, P.H., Lose, G., Prevalence of endometrial polyps and abnormal uterine bleeding in a Danish population aged 20-74 years (2009) Ultrasound Obstet Gynecol., 33 (1), pp. 102-108Lieng, M., Istre, O., Sandvik, L., Qvigstad, E., Prevalence, 1-year regression rate, and clinical significance of asymptomatic endometrial polyps: Cross-sectional study (2009) J Minim Invasive Gynecol., 16 (4), pp. 465-471Schmidt, T., Breidenbach, M., Nawroth, F., Mallmann, P., Beyer, I.M., Fleisch, M.C., Hysteroscopy for asymptomatic postmenopausal women with sonographically thickened endometrium (2009) Maturitas., 62 (2), pp. 176-178Lee, S.C., Kaunitz, A.M., Sanchez-Ramos, L., Rhatigan, R.M., The oncogenic potential of endometrial polyps: A systematic review and meta-analysis (2010) Obstet Gynecol., 116 (5), pp. 1197-1205Martínez, M.A., Jou, P., Nonell, R., Cardona, M., Alonso, I., Vanrell, J.A., Pólipos endometriales: Riesgo de malignización y correlación clínico-anatómica (2004) Prog Obstet Ginecol., 47 (11), pp. 506-510Antunes Jr., A., Costa-Paiva, L., Arthuso, M., Costa, J.V., Pinto-Neto, A.M., Endometrial polyps in pre-and postmenopausal women: Factors associated with malignancy (2007) Maturitas., 57 (4), pp. 415-421Savelli, L., de Iaco, P., Santini, D., Rosati, F., Ghi, T., Pignotti, E., Histopathologic features and risk factors for benignity, hyperplasia, and cancer in endometrial polyps (2003) Am J Obstet Gynecol., 188 (4), pp. 927-931Lieng, M., Istre, O., Qvigstad, E., Treatment of endometrial polyps: A systematic review (2010) Acta Obstet Gynecol Scand., 89 (8), pp. 992-1002Baiocchi, G., Manci, N., Pazzaglia, M., Giannone, L., Burnelli, L., Giannone, E., Malignancy in endometrial polyps: A 12-year experience (2009) Am J Obstet Gynecol., 201 (5), pp. 462. e1-462. e4Rahimi, S., Marani, C., Renzi, C., Natale, M.E., Giovannini, P., Zeloni, R., Endometrial polyps and the risk of atypical hyperplasia on biopsies of unremarkable endometrium: A study on 694 patients with benign endometrial polyps (2009) Int J Gynecol Pathol., 28 (6), pp. 522-528Ben-Arie, A., Goldchmit, C., Laviv, Y., Levy, R., Caspi, B., Huszar, M., The malignant potential of endometrial polyps (2004) Eur J Obstet Gynecol Reprod Biol., 115 (2), pp. 206-210Ferrazzi, E., Zupi, E., Leone, F.P., Savelli, L., Omodei, U., Moscarini, M., How often are endometrial polyps malignant in asymptomatic postmenopausal women? A multicenter study (2009) Am J Obstet Gynecol., 200 (3), pp. 235. e1-235. e6Whiting, P., Rutjes, A.W., Reitsma, J.B., Bossuyt, P.M., Kleijnen, J., The development of QUADAS: A tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews (2003) BMC Med Res Methodol., 3, p. 25Osmers, R., Völksen, M., Schauer, A., Vaginosonography for early detection of endometrial carcinoma? (1990) Lancet., 335 (8705), pp. 1569-1571Seelbach-Göbel, B., Rempen, A., Kristen, P., Vaginal sonography of the endometrium in postmenopause. Initial results of a prospective study (1991) Gynakol Rundsch., 31 (SUPPL. 2), pp. 253-255. , GermanGrimbizis, G.F., Tsolakidis, D., Mikos, T., Anagnostou, E., Asimakopoulos, E., Stamatopoulos, P., A prospective comparison of transvaginal ultrasound, saline infusion sonohysterography, and diagnostic hysteroscopy in the evaluation of endometrial pathology (2010) Fertil Steril., 94 (7), pp. 2720-2725Weigel, M., Friese, K., Strittmatter, H.J., Melchert, F., Ultrasound assessment of the postmenopausal endometrium (1994) Is measuring thickness adequate?] Ultraschall Med., 15 (3), pp. 117-121. , GermanCepni, I., Ocal, P., Erkan, S., Saricali, F.S., Akbas, H., Demirkiran, F., Comparison of transvaginal sonography, saline infusion sonography and hysteroscopy in the evaluation of uterine cavity pathologies (2005) Aust N Z J Obstet Gynaecol., 45 (1), pp. 30-35Jacobs, I., Gentry-Maharaj, A., Burnell, M., Manchanda, R., Singh, N., Sharma, A., Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: A case-control study within the UKCTOCS cohort (2011) Lancet Oncol., 12 (1), pp. 38-48Wang, J.H., Zhao, J., Lin, J., Opportunities and risk factors for premalignant and malignant transformation of endometrial polyps: Management strategies (2010) J Minim Invasive Gynecol., 17 (1), pp. 53-58Fernández-Parra, J., Rodríguez Oliver, A., López Criado, S., Parrilla Fernández, F., Montoya Ventoso, F., Hysteroscopic evaluation of endometrial polyps (2006) Int J Gynaecol Obstet., 95 (2), pp. 144-148Shushan, A., Revel, A., Rojansky, N., How often are endometrial polyps malignant? (2004) Gynecol Obstet Invest., 58 (4), pp. 212-215Gregoriou, O., Konidaris, S., Vrachnis, N., Bakalianou, K., Salakos, N., Papadias, K., Clinical parameters linked with malignancy in endometrial polyps (2009) Climacteric., 12 (5), pp. 454-458Krampl, E., Bourne, T., Hurlen-Solbakken, H., Istre, O., Transvaginal ultrasonography sonohysterography and operative hysteroscopy for the evaluation of abnormal uterine bleeding (2001) Acta Obstet Gynecol Scand., 80 (7), pp. 616-622Salim, S., Won, H., Nesbitt-Hawes, E., Campbell, N., Abbott, J., Diagnosis and management of endometrial polyps: A critical review of the literature (2011) J Minim Invasive Gynecol., 18 (5), pp. 569-581AAGL practice report: Practice guidelines for the diagnosis and management of endometrial polyps (2012) J Minim Invasive Gynecol., 19 (1), pp. 3-10. , American Association of Gynecologic Laparoscopist